Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Scharf

Showing results (111-120 of 145) with videos related to

Pageof 15
Sort By:
The Journal of Biological Chemistry|May 27, 1994
The primary structure of halocyanin, an archaeal blue copper protein, predicts a lipid anchor for membrane fixationS Mattar, B Scharf, S B Kent, et al.
Journal of Clinical Pharmacology|August 1, 1976
Hypnotic efficacy of triazolam: sleep laboratory evaluation of intermediate-term effectivenessA Kales, J D Kales, E O Bixler, et al.
Sleep|September 16, 2008
Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakeningsThomas Roth, Steven G Hull, D Alan Lankford, et al.
The Psychiatric Clinics of North America|December 1, 1987
Childhood enuresis. A comprehensive treatment programM B Scharf, M F Pravda, S W Jennings, et al.
Biochemistry|September 26, 1995
Ligand binding and protein dynamics in cupredoxinsD Ehrenstein, M Filiaci, B Scharf, et al.
JAMA|February 4, 1974
Chronic hypnotic-drug use. Ineffectiveness, drug-withdrawal insomnia, and dependenceA Kales, E O Bixler, T L Tan, et al.
Pharmacology|January 1, 1978
Hypnotic effectiveness of sodium salicylamide with short-term use: sleep laboratory studiesC R Soldatos, A Kales, E O Bixler, et al.
Life Sciences|October 15, 1979
Effects of hypnotic drugs on memoryE O Bixler, M B Scharf, C R Soldatos, et al.
Clinical Pharmacology and Therapeutics|February 1, 1982
Lorazepam-efficacy, side effects, and rebound phenomenaM B Scharf, A Kales, E O Bixler, et al.
Clinical Pharmacology and Therapeutics|March 1, 1971
Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administrationA Kales, R D Ansel, C H Markham, et al.
Pageof 15

Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
The Journal of Biological Chemistry|May 27, 1994
The primary structure of halocyanin, an archaeal blue copper protein, predicts a lipid anchor for membrane fixationS Mattar, B Scharf, S B Kent, et al.
Journal of Clinical Pharmacology|August 1, 1976
Hypnotic efficacy of triazolam: sleep laboratory evaluation of intermediate-term effectivenessA Kales, J D Kales, E O Bixler, et al.
Sleep|September 16, 2008
Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakeningsThomas Roth, Steven G Hull, D Alan Lankford, et al.
The Psychiatric Clinics of North America|December 1, 1987
Childhood enuresis. A comprehensive treatment programM B Scharf, M F Pravda, S W Jennings, et al.
Biochemistry|September 26, 1995
Ligand binding and protein dynamics in cupredoxinsD Ehrenstein, M Filiaci, B Scharf, et al.
JAMA|February 4, 1974
Chronic hypnotic-drug use. Ineffectiveness, drug-withdrawal insomnia, and dependenceA Kales, E O Bixler, T L Tan, et al.
Pharmacology|January 1, 1978
Hypnotic effectiveness of sodium salicylamide with short-term use: sleep laboratory studiesC R Soldatos, A Kales, E O Bixler, et al.
Life Sciences|October 15, 1979
Effects of hypnotic drugs on memoryE O Bixler, M B Scharf, C R Soldatos, et al.
Clinical Pharmacology and Therapeutics|February 1, 1982
Lorazepam-efficacy, side effects, and rebound phenomenaM B Scharf, A Kales, E O Bixler, et al.
Clinical Pharmacology and Therapeutics|March 1, 1971
Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administrationA Kales, R D Ansel, C H Markham, et al.
Pageof 15